Skip to main content

Animations

MJFF Publications

3981 - 3990 of 6547 Results
Title
Year
  • Year
  • 2024
  • 2018
  • 2015
  • 2018
  • 2020
  • 2017
  • 2020
  • 2017
  • 2020
  • 2016
  • Summary Details
    OPEN
    Title: Clinical and neuroradiological spectrum of biallelic variants in NOTCH3
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2024.105297
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.003
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/cb5010417
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2017.00734
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Predicting primary progressive aphasias with support vector machine approaches in structural MRI data
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.003
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Mutant Allele-Specific CRISPR Disruption in DYT1 Dystonia Fibroblasts Restores Cell Function
    Journal Name: Molecular Therapy Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2020.05.009
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Traumatic brain injury in the prodromal period of Parkinson's disease: A large epidemiological study using medicare data
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25074
    Citation Count: 48
  • Summary Details
    OPEN
    Title: ADNC-RS, a clinical-genetic risk score, predicts Alzheimer’s pathology in autopsy-confirmed Parkinson’s disease and Dementia with Lewy bodies
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-020-02199-7
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Preparation of S-glycoside surfactants and cysteine thioglycosides using minimally competent Lewis acid catalysis
    Journal Name: Carbohydrate Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.carres.2015.12.008
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.